MedPath

Gastrointestinal Tract Microbiome in Healthy Term Infants Receiving Mother'S-own Breast Milk or Cow's Milk-based Infant Formulas

Not Applicable
Terminated
Conditions
Gastrointestinal Microbiome
Registration Number
NCT04059666
Lead Sponsor
Mead Johnson Nutrition
Brief Summary

This clinical trial will compare stool and oral microbiome composition between infants fed breast milk or one of two infant formulas for a 60 day feeding period.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
57
Inclusion Criteria
  • 7-18 days of age at Visit 1
  • Singleton birth
  • Gestational age of 37-42 weeks
  • Birth weight of 2500 g (5 lbs 8 oz) or more
  • Parent or legal guardian agrees not to enroll infant in another interventional clinical study while participating in this study
  • Signed informed consent and use of PHI for infant and birth mother
  • Receipt of three protocol-compliant Baseline stool samples

Infants receiving formula:

  • Exclusively receiving infant formula for at least 24 hours prior to randomization
  • Parent(s) or legal guardian has full intention to exclusively feed study formula during the study period

Infants receiving human milk:

  • Mother has intention to exclusively provide mother's-own breast milk for the duration of the study
Exclusion Criteria
  • Caesarean delivery
  • Infant consumption of donor milk prior to randomization/registration
  • Maternal antibiotic use within 48 hours prior to or at time of delivery
  • Maternal antibiotic use while providing mother's-own breast milk to infant
  • Infant use of systemic antibiotics prior to randomization/registration
  • Any signs of an acute infection (i.e. fever, diarrhea) at randomization/registration
  • Weight at Visit 1 is <95% of birth weight
  • Infant use of probiotics
  • Evidence of significant feeding difficulties
  • Infant was born large for gestational age
  • History of underlying metabolic or chronic disease or congenital malformation
  • Infant is immunocompromised

Infants receiving human milk:

  • Consumption of infant formula from 1 day of age

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Comparison of stool microbiome between breast fed and formula fed babiesOver 60 days

Stool collection

Secondary Outcome Measures
NameTimeMethod
24 hour recall of formula intake2 times over 60 days

24 hour recall questionnaire

Stool molecules at each visitOver 60 days

Stool sample

Stool color and consistency3 times over 60 days

Color and consistency

Oral microbiome at each visitOver 60 days

Buccal swab

Medically confirmed adverse events60 days

Medically confirmed adverse events

Stool pHOver 60 days

pH

Trial Locations

Locations (5)

Birmingham Pediatric Associates

🇺🇸

Birmingham, Alabama, United States

Children's Research, LLC

🇺🇸

Altamonte Springs, Florida, United States

Owensboro Pediatrics

🇺🇸

Owensboro, Kentucky, United States

Holston Medical Group

🇺🇸

Kingsport, Tennessee, United States

Memphis & Shelby County Pediatric

🇺🇸

Memphis, Tennessee, United States

Birmingham Pediatric Associates
🇺🇸Birmingham, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.